<?xml version="1.0" encoding="UTF-8"?>
<!-- This sitemap was dynamically generated on April 13, 2026 at 7:49 AM by All in One SEO v4.9.5.1 - the original SEO plugin for WordPress. -->

<?xml-stylesheet type="text/xsl" href="https://cgxpwire.com/default-sitemap.xsl"?>

<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
	<channel>
		<title>cGxP.wire</title>
		<link><![CDATA[https://cgxpwire.com]]></link>
		<description><![CDATA[cGxP.wire]]></description>
		<lastBuildDate><![CDATA[Thu, 09 Apr 2026 09:07:21 +0000]]></lastBuildDate>
		<docs>https://validator.w3.org/feed/docs/rss2.html</docs>
		<atom:link href="https://cgxpwire.com/sitemap.rss" rel="self" type="application/rss+xml" />
		<ttl><![CDATA[60]]></ttl>

		<item>
			<guid><![CDATA[https://cgxpwire.com/medical-devices-diagnostics-radiation-emitting/avista-acquires-bentec-to-expand-medtech-manufacturing/]]></guid>
			<link><![CDATA[https://cgxpwire.com/medical-devices-diagnostics-radiation-emitting/avista-acquires-bentec-to-expand-medtech-manufacturing/]]></link>
			<title>Avista Healthcare Partners Acquires Bentec to Expand MedTech Manufacturing</title>
			<pubDate><![CDATA[Thu, 09 Apr 2026 09:07:21 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://cgxpwire.com/biopharma/nxera-pharma-advances-schizophrenia-drug-to-phase-2/]]></guid>
			<link><![CDATA[https://cgxpwire.com/biopharma/nxera-pharma-advances-schizophrenia-drug-to-phase-2/]]></link>
			<title>Nxera Pharma Advances Schizophrenia Drug to Phase 2</title>
			<pubDate><![CDATA[Mon, 13 Apr 2026 09:53:34 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://cgxpwire.com/biopharma/regeneron-dupixent-eu-approval-expands-pediatric-csu-care/]]></guid>
			<link><![CDATA[https://cgxpwire.com/biopharma/regeneron-dupixent-eu-approval-expands-pediatric-csu-care/]]></link>
			<title>Regeneron Dupixent EU Approval Expands Pediatric CSU Care</title>
			<pubDate><![CDATA[Mon, 13 Apr 2026 09:30:28 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://cgxpwire.com/medical-devices-diagnostics-radiation-emitting/roche-gets-ce-mark-for-elecsys-nfl-ms-blood-test/]]></guid>
			<link><![CDATA[https://cgxpwire.com/medical-devices-diagnostics-radiation-emitting/roche-gets-ce-mark-for-elecsys-nfl-ms-blood-test/]]></link>
			<title>Roche Gets CE Mark for Elecsys NfL MS Blood Test</title>
			<pubDate><![CDATA[Mon, 13 Apr 2026 09:06:41 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://cgxpwire.com/biopharma/anbogen-therapeutics-showcases-abt-301-cancer-breakthroughs/]]></guid>
			<link><![CDATA[https://cgxpwire.com/biopharma/anbogen-therapeutics-showcases-abt-301-cancer-breakthroughs/]]></link>
			<title>AnBogen Therapeutics Showcases ABT-301 Cancer Breakthroughs</title>
			<pubDate><![CDATA[Mon, 13 Apr 2026 08:56:24 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://cgxpwire.com/biopharma/abbvie-reports-strong-phase-2-data-in-ovarian-cancer/]]></guid>
			<link><![CDATA[https://cgxpwire.com/biopharma/abbvie-reports-strong-phase-2-data-in-ovarian-cancer/]]></link>
			<title>AbbVie Reports Strong Phase 2 Data in Ovarian Cancer</title>
			<pubDate><![CDATA[Mon, 13 Apr 2026 07:39:02 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://cgxpwire.com/clinical-trial-research/spyre-to-reveal-skyline-uc-trial-results-on-april-13/]]></guid>
			<link><![CDATA[https://cgxpwire.com/clinical-trial-research/spyre-to-reveal-skyline-uc-trial-results-on-april-13/]]></link>
			<title>Spyre to Reveal SKYLINE UC Trial Results on April 13</title>
			<pubDate><![CDATA[Mon, 13 Apr 2026 07:33:12 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://cgxpwire.com/biopharma/replimune-rp1-melanoma-drug-faces-fda-rejection/]]></guid>
			<link><![CDATA[https://cgxpwire.com/biopharma/replimune-rp1-melanoma-drug-faces-fda-rejection/]]></link>
			<title>Replimune RP1 Melanoma Drug Faces FDA Rejection</title>
			<pubDate><![CDATA[Mon, 13 Apr 2026 07:19:10 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://cgxpwire.com/clinical-trial-research/allogene-to-reveal-alpha3-car-t-trial-data-soon/]]></guid>
			<link><![CDATA[https://cgxpwire.com/clinical-trial-research/allogene-to-reveal-alpha3-car-t-trial-data-soon/]]></link>
			<title>Allogene to Reveal ALPHA3 CAR-T Trial Data Soon</title>
			<pubDate><![CDATA[Mon, 13 Apr 2026 07:05:48 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://cgxpwire.com/biopharma/ideaya-to-reveal-phase-3-melanoma-trial-results-soon/]]></guid>
			<link><![CDATA[https://cgxpwire.com/biopharma/ideaya-to-reveal-phase-3-melanoma-trial-results-soon/]]></link>
			<title>IDEAYA to Reveal Phase 3 Melanoma Trial Results Soon</title>
			<pubDate><![CDATA[Mon, 13 Apr 2026 06:47:48 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://cgxpwire.com/biopharma/imagene-ai-daiichi-sankyo-advance-oncology-biomarkers/]]></guid>
			<link><![CDATA[https://cgxpwire.com/biopharma/imagene-ai-daiichi-sankyo-advance-oncology-biomarkers/]]></link>
			<title>Imagene AI, Daiichi Sankyo Advance Oncology Biomarkers</title>
			<pubDate><![CDATA[Mon, 13 Apr 2026 06:42:17 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://cgxpwire.com/pharma/telix-nda-accepted-for-pixclara-brain-cancer-imaging/]]></guid>
			<link><![CDATA[https://cgxpwire.com/pharma/telix-nda-accepted-for-pixclara-brain-cancer-imaging/]]></link>
			<title>Telix NDA Accepted for Pixclara Brain Cancer Imaging</title>
			<pubDate><![CDATA[Mon, 13 Apr 2026 06:08:57 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://cgxpwire.com/medical-devices-diagnostics-radiation-emitting/johnson-johnson-showcases-tecnis-puresee-iol-data/]]></guid>
			<link><![CDATA[https://cgxpwire.com/medical-devices-diagnostics-radiation-emitting/johnson-johnson-showcases-tecnis-puresee-iol-data/]]></link>
			<title>Johnson &amp; Johnson Showcases TECNIS PureSee IOL Data</title>
			<pubDate><![CDATA[Mon, 13 Apr 2026 06:04:37 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://cgxpwire.com/biopharma/insilico-medicine-advances-ism6200-for-cancer-therapy/]]></guid>
			<link><![CDATA[https://cgxpwire.com/biopharma/insilico-medicine-advances-ism6200-for-cancer-therapy/]]></link>
			<title>Insilico Medicine Advances ISM6200 for Cancer Therapy</title>
			<pubDate><![CDATA[Mon, 13 Apr 2026 05:54:31 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://cgxpwire.com/pharma/lupin-launches-dapagliflozin-tablets-in-u-s-market/]]></guid>
			<link><![CDATA[https://cgxpwire.com/pharma/lupin-launches-dapagliflozin-tablets-in-u-s-market/]]></link>
			<title>Lupin Launches Dapagliflozin Tablets in U.S. Market</title>
			<pubDate><![CDATA[Mon, 13 Apr 2026 05:46:08 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://cgxpwire.com/biopharma/fibrobiologics-advances-thymus-organoid-cancer-therapy/]]></guid>
			<link><![CDATA[https://cgxpwire.com/biopharma/fibrobiologics-advances-thymus-organoid-cancer-therapy/]]></link>
			<title>FibroBiologics Advances Thymus Organoid Cancer Therapy</title>
			<pubDate><![CDATA[Mon, 13 Apr 2026 05:36:45 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://cgxpwire.com/pharma/sobi-gains-canada-approval-for-empaveli-kidney-drug/]]></guid>
			<link><![CDATA[https://cgxpwire.com/pharma/sobi-gains-canada-approval-for-empaveli-kidney-drug/]]></link>
			<title>Sobi Gains Canada Approval for EMPAVELI Kidney Drug</title>
			<pubDate><![CDATA[Mon, 13 Apr 2026 05:32:00 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://cgxpwire.com/biopharma/oxford-biotherapeutics-bristol-myers-squibb-advance-t-cell-therapies/]]></guid>
			<link><![CDATA[https://cgxpwire.com/biopharma/oxford-biotherapeutics-bristol-myers-squibb-advance-t-cell-therapies/]]></link>
			<title>Oxford BioTherapeutics, Bristol Myers Squibb Advance T-Cell Therapies</title>
			<pubDate><![CDATA[Mon, 13 Apr 2026 05:22:28 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://cgxpwire.com/biopharma/kymera-gilead-deal-advances-cdk2-cancer-therapy/]]></guid>
			<link><![CDATA[https://cgxpwire.com/biopharma/kymera-gilead-deal-advances-cdk2-cancer-therapy/]]></link>
			<title>Kymera-Gilead Deal Advances CDK2 Cancer Therapy</title>
			<pubDate><![CDATA[Mon, 13 Apr 2026 05:14:46 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://cgxpwire.com/pharma/emergent-expands-narcan-supply-in-bc-opioid-program/]]></guid>
			<link><![CDATA[https://cgxpwire.com/pharma/emergent-expands-narcan-supply-in-bc-opioid-program/]]></link>
			<title>Emergent Expands NARCAN Supply in BC Opioid Program</title>
			<pubDate><![CDATA[Fri, 10 Apr 2026 10:48:25 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://cgxpwire.com/biopharma/vedanta-biosciences-advances-microbiome-drugs-at-escmid-2026/]]></guid>
			<link><![CDATA[https://cgxpwire.com/biopharma/vedanta-biosciences-advances-microbiome-drugs-at-escmid-2026/]]></link>
			<title>Vedanta Biosciences Advances Microbiome Drugs at ESCMID 2026</title>
			<pubDate><![CDATA[Fri, 10 Apr 2026 10:35:58 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://cgxpwire.com/pharma/vanda-urges-fda-to-reject-extended-drug-review-timelines/]]></guid>
			<link><![CDATA[https://cgxpwire.com/pharma/vanda-urges-fda-to-reject-extended-drug-review-timelines/]]></link>
			<title>Vanda Urges FDA to Reject Extended Drug Review Timelines</title>
			<pubDate><![CDATA[Fri, 10 Apr 2026 10:27:38 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://cgxpwire.com/biopharma/jazz-pharmaceuticals-presents-neurology-drug-data-at-aan/]]></guid>
			<link><![CDATA[https://cgxpwire.com/biopharma/jazz-pharmaceuticals-presents-neurology-drug-data-at-aan/]]></link>
			<title>Jazz Pharmaceuticals Presents Neurology Drug Data at AAN</title>
			<pubDate><![CDATA[Fri, 10 Apr 2026 10:21:53 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://cgxpwire.com/biopharma/innovent-showcases-tri-specific-autoimmune-therapy-data/]]></guid>
			<link><![CDATA[https://cgxpwire.com/biopharma/innovent-showcases-tri-specific-autoimmune-therapy-data/]]></link>
			<title>Innovent Showcases Tri-Specific Autoimmune Therapy Data</title>
			<pubDate><![CDATA[Fri, 10 Apr 2026 10:15:12 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://cgxpwire.com/medical-devices-diagnostics-radiation-emitting/heartfocus-inteleos-launch-ai-cardiac-pocus-certification/]]></guid>
			<link><![CDATA[https://cgxpwire.com/medical-devices-diagnostics-radiation-emitting/heartfocus-inteleos-launch-ai-cardiac-pocus-certification/]]></link>
			<title>HeartFocus, Inteleos Launch AI Cardiac POCUS Certification</title>
			<pubDate><![CDATA[Fri, 10 Apr 2026 10:09:22 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://cgxpwire.com/cosmetics/revision-skincare-validates-vitamin-c-serum-in-clinical-studies/]]></guid>
			<link><![CDATA[https://cgxpwire.com/cosmetics/revision-skincare-validates-vitamin-c-serum-in-clinical-studies/]]></link>
			<title>Revision Skincare Validates Vitamin C Serum in Clinical Studies</title>
			<pubDate><![CDATA[Fri, 10 Apr 2026 09:57:11 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://cgxpwire.com/biopharma/dualitybio-advances-her2-adc-toward-china-approval/]]></guid>
			<link><![CDATA[https://cgxpwire.com/biopharma/dualitybio-advances-her2-adc-toward-china-approval/]]></link>
			<title>DualityBio Advances HER2 ADC Toward China Approval</title>
			<pubDate><![CDATA[Fri, 10 Apr 2026 09:47:30 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://cgxpwire.com/medical-devices-diagnostics-radiation-emitting/waters-wins-fda-clearance-for-at-home-hpv-cancer-test/]]></guid>
			<link><![CDATA[https://cgxpwire.com/medical-devices-diagnostics-radiation-emitting/waters-wins-fda-clearance-for-at-home-hpv-cancer-test/]]></link>
			<title>Waters Wins FDA Clearance for At-Home HPV Cancer Test</title>
			<pubDate><![CDATA[Thu, 09 Apr 2026 17:53:37 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://cgxpwire.com/pharma/difgen-apotex-win-fda-approval-for-nintedanib-capsules/]]></guid>
			<link><![CDATA[https://cgxpwire.com/pharma/difgen-apotex-win-fda-approval-for-nintedanib-capsules/]]></link>
			<title>DifGen, Apotex Win FDA Approval for Nintedanib Capsules</title>
			<pubDate><![CDATA[Fri, 10 Apr 2026 09:24:17 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://cgxpwire.com/clinical-trial-research/vanda-initiates-thetis-trial-for-glp-1-vomiting-prevention/]]></guid>
			<link><![CDATA[https://cgxpwire.com/clinical-trial-research/vanda-initiates-thetis-trial-for-glp-1-vomiting-prevention/]]></link>
			<title>Vanda Initiates Thetis Trial for GLP-1 Vomiting Prevention</title>
			<pubDate><![CDATA[Thu, 09 Apr 2026 17:45:19 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://cgxpwire.com/veterinary/boehringer-supports-ecuador-rabies-elimination-program/]]></guid>
			<link><![CDATA[https://cgxpwire.com/veterinary/boehringer-supports-ecuador-rabies-elimination-program/]]></link>
			<title>Boehringer Supports Ecuador Rabies Elimination Program</title>
			<pubDate><![CDATA[Fri, 10 Apr 2026 09:12:07 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://cgxpwire.com/food/iherb-expands-global-reach-with-kylie-jenner-k2o-launch/]]></guid>
			<link><![CDATA[https://cgxpwire.com/food/iherb-expands-global-reach-with-kylie-jenner-k2o-launch/]]></link>
			<title>iHerb Expands Global Reach with Kylie Jenner k2o Launch</title>
			<pubDate><![CDATA[Fri, 10 Apr 2026 09:06:50 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://cgxpwire.com/biopharma/dyno-ai-capsid-licensed-by-astellas-for-gene-therapy/]]></guid>
			<link><![CDATA[https://cgxpwire.com/biopharma/dyno-ai-capsid-licensed-by-astellas-for-gene-therapy/]]></link>
			<title>Dyno AI Capsid Licensed by Astellas for Gene Therapy</title>
			<pubDate><![CDATA[Thu, 09 Apr 2026 10:57:44 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://cgxpwire.com/medical-devices-diagnostics-radiation-emitting/alivecor-expands-ai-cardiac-ecg-technology-in-vietnam/]]></guid>
			<link><![CDATA[https://cgxpwire.com/medical-devices-diagnostics-radiation-emitting/alivecor-expands-ai-cardiac-ecg-technology-in-vietnam/]]></link>
			<title>AliveCor Expands AI Cardiac ECG Technology in Vietnam</title>
			<pubDate><![CDATA[Fri, 10 Apr 2026 08:58:27 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://cgxpwire.com/mergers-acquisitions/garda-to-acquire-assertio-in-125m-pharma-deal/]]></guid>
			<link><![CDATA[https://cgxpwire.com/mergers-acquisitions/garda-to-acquire-assertio-in-125m-pharma-deal/]]></link>
			<title>Garda to Acquire Assertio in $125M Pharma Deal</title>
			<pubDate><![CDATA[Thu, 09 Apr 2026 10:19:38 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://cgxpwire.com/clinical-trial-research/fortrea-launches-ai-powered-fit-platform-to-transform-clinical-trials/]]></guid>
			<link><![CDATA[https://cgxpwire.com/clinical-trial-research/fortrea-launches-ai-powered-fit-platform-to-transform-clinical-trials/]]></link>
			<title>Fortrea Launches AI-Powered FIT Platform to Transform Clinical Trials</title>
			<pubDate><![CDATA[Thu, 09 Apr 2026 09:48:34 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://cgxpwire.com/medical-devices-diagnostics-radiation-emitting/merit-medical-acquires-view-point-to-expand-oncology-devices/]]></guid>
			<link><![CDATA[https://cgxpwire.com/medical-devices-diagnostics-radiation-emitting/merit-medical-acquires-view-point-to-expand-oncology-devices/]]></link>
			<title>Merit Medical Acquires View Point to Expand Oncology Devices</title>
			<pubDate><![CDATA[Thu, 09 Apr 2026 09:34:13 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://cgxpwire.com/biopharma/immutrin-raises-87m-to-advance-amyloidosis-antibody-therapy/]]></guid>
			<link><![CDATA[https://cgxpwire.com/biopharma/immutrin-raises-87m-to-advance-amyloidosis-antibody-therapy/]]></link>
			<title>Immutrin Raises $87M to Advance Amyloidosis Antibody Therapy</title>
			<pubDate><![CDATA[Thu, 09 Apr 2026 09:25:57 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://cgxpwire.com/clinical-trial-research/memorialcare-joins-fastest-trial-for-stroke-therapy/]]></guid>
			<link><![CDATA[https://cgxpwire.com/clinical-trial-research/memorialcare-joins-fastest-trial-for-stroke-therapy/]]></link>
			<title>MemorialCare Joins FASTEST Trial for Stroke Therapy</title>
			<pubDate><![CDATA[Thu, 09 Apr 2026 09:19:20 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://cgxpwire.com/biopharma/gsk-secures-china-approval-for-exdensur-in-nasal-polyps-treatment/]]></guid>
			<link><![CDATA[https://cgxpwire.com/biopharma/gsk-secures-china-approval-for-exdensur-in-nasal-polyps-treatment/]]></link>
			<title>GSK Secures China Approval for Exdensur in Nasal Polyps Treatment</title>
			<pubDate><![CDATA[Thu, 09 Apr 2026 09:18:06 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://cgxpwire.com/biopharma/phanes-advances-spevatamig-to-expansion-in-btc-trial/]]></guid>
			<link><![CDATA[https://cgxpwire.com/biopharma/phanes-advances-spevatamig-to-expansion-in-btc-trial/]]></link>
			<title>Phanes Advances Spevatamig to Expansion in BTC Trial</title>
			<pubDate><![CDATA[Thu, 09 Apr 2026 09:06:40 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://cgxpwire.com/medical-devices-diagnostics-radiation-emitting/anumana-gains-fda-clearance-for-ecg-ai-amyloidosis-tool/]]></guid>
			<link><![CDATA[https://cgxpwire.com/medical-devices-diagnostics-radiation-emitting/anumana-gains-fda-clearance-for-ecg-ai-amyloidosis-tool/]]></link>
			<title>Anumana Gains FDA Clearance for ECG-AI Amyloidosis Tool</title>
			<pubDate><![CDATA[Thu, 09 Apr 2026 09:00:00 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://cgxpwire.com/biopharma/boehringer-advances-novel-combo-therapy-in-sclc-trial/]]></guid>
			<link><![CDATA[https://cgxpwire.com/biopharma/boehringer-advances-novel-combo-therapy-in-sclc-trial/]]></link>
			<title>Boehringer Advances Novel Combo Therapy in SCLC Trial</title>
			<pubDate><![CDATA[Fri, 10 Apr 2026 08:50:11 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://cgxpwire.com/biopharma/c4-and-roche-expand-dac-cancer-drug-collaboration/]]></guid>
			<link><![CDATA[https://cgxpwire.com/biopharma/c4-and-roche-expand-dac-cancer-drug-collaboration/]]></link>
			<title>C4 and Roche Expand DAC Cancer Drug Collaboration</title>
			<pubDate><![CDATA[Fri, 10 Apr 2026 08:45:01 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://cgxpwire.com/clinical-trial-research/alpheus-medical-starts-phase-2b-trial-in-glioblastoma/]]></guid>
			<link><![CDATA[https://cgxpwire.com/clinical-trial-research/alpheus-medical-starts-phase-2b-trial-in-glioblastoma/]]></link>
			<title>Alpheus Medical Starts Phase 2b Trial in Glioblastoma</title>
			<pubDate><![CDATA[Fri, 10 Apr 2026 06:57:07 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://cgxpwire.com/pharma/glenmark-pharmaceuticals-gains-fda-nod-for-progesterone/]]></guid>
			<link><![CDATA[https://cgxpwire.com/pharma/glenmark-pharmaceuticals-gains-fda-nod-for-progesterone/]]></link>
			<title>Glenmark Pharmaceuticals Gains FDA Nod for Progesterone</title>
			<pubDate><![CDATA[Fri, 10 Apr 2026 05:55:52 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://cgxpwire.com/biopharma/oricell-therapeutics-secures-110m-for-car-t-expansion/]]></guid>
			<link><![CDATA[https://cgxpwire.com/biopharma/oricell-therapeutics-secures-110m-for-car-t-expansion/]]></link>
			<title>Oricell Therapeutics Secures $110M for CAR-T Expansion</title>
			<pubDate><![CDATA[Fri, 10 Apr 2026 05:32:08 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://cgxpwire.com/biopharma/decoy-therapeutics-advances-ai-antiviral-pipeline-fast/]]></guid>
			<link><![CDATA[https://cgxpwire.com/biopharma/decoy-therapeutics-advances-ai-antiviral-pipeline-fast/]]></link>
			<title>Decoy Therapeutics Advances AI Antiviral Pipeline Fast</title>
			<pubDate><![CDATA[Fri, 10 Apr 2026 05:06:58 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://cgxpwire.com/pharma/lilly-launches-foundayo-oral-glp-1-weight-loss-drug/]]></guid>
			<link><![CDATA[https://cgxpwire.com/pharma/lilly-launches-foundayo-oral-glp-1-weight-loss-drug/]]></link>
			<title>Lilly Launches Foundayo Oral GLP-1 Weight Loss Drug</title>
			<pubDate><![CDATA[Fri, 10 Apr 2026 04:44:01 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://cgxpwire.com/biopharma/arkbio-advances-ak0406-phase-i-trial-for-influenza/]]></guid>
			<link><![CDATA[https://cgxpwire.com/biopharma/arkbio-advances-ak0406-phase-i-trial-for-influenza/]]></link>
			<title>ArkBio Advances AK0406 Phase I Trial for Influenza</title>
			<pubDate><![CDATA[Fri, 10 Apr 2026 04:25:33 +0000]]></pubDate>
		</item>
				</channel>
</rss>
